Catalyst Wire Dossier Catalyst Wire Dossier

TAK-536 pediatric formulation

· Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-536 pediatric formulation, covering 2018-10-09 to 2018-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation [Phase 1]

See pricing